Malignant Catatonia Induced by Concurrent Opioid and Benzodiazepine Withdrawal

Prim Care Companion CNS Disord. 2023 Mar 16;25(2):22cr03346. doi: 10.4088/PCC.22cr03346.

Authors

Brian D Sayles¹, Emily G Royer², VaKara M Meyer², Alëna A Balasanova^{2

3}

Affiliations

¹ College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
² Department of Psychiatry, University of Nebraska Medical Center, Omaha, Nebraska.
³ Corresponding author: Alëna A. Balasanova, MD, Department of Psychiatry, Poynter Hall 5th Floor, University of Nebraska Medical Center, 985578 Nebraska Medical Center, Omaha, NE 68198-5578 ([email protected]).

PMID: 36946574
DOI: 10.4088/PCC.22cr03346

No abstract available

MeSH terms

Analgesics, Opioid / adverse effects
Benzodiazepines / adverse effects
Catatonia* / chemically induced
Humans
Substance Withdrawal Syndrome* / drug therapy

Substances

Analgesics, Opioid
Benzodiazepines